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This study reports the formation of 5-FU co-crystals with four different pharmacologically safe co-
formers; Urea, Thiourea, Acetanilide and Aspirin using methanol as a solvent. Two fabrication schemes
were followed i.e., solid-state grinding protocol, in which API and co-formers were mixed through vigor-
ous grinding while in the other method separate solutions of both the components were made and mixed
together. The adopted approaches offer easy fabrication protocols, no temperature maintenance require-
ments, no need of expensive solvents, hardly available apparatus, isolation and purification of the desired
products. In addition, there is no byproducts formation, In fact, a phenomenon embracing the require-
ments of green synthesis. Through FTIR analysis; for API the NAH absorption frequency was recorded
at 3409.02 cm1 and that of AC@O was observed at 1647.77 cm1. These characteristics peaks of 5-FU
were significantly shifted and recorded at 3499.40 cm1 and 1649.62 cm1 for 5-FU-Ac (3B) and
3496.39 cm1 and 1659.30 cm1 for 5-FU-As (4B) co-crystals for NAH and AC@O groups respectively.
The structural differences between API and co-crystals were further confirmed through PXRD analysis.
The characteristic peak of 5-FU at 2h = 28.79918o was significantly shifted in the graphs of co-crystals
not only in position but also with respect to intensity and FWHM values. In addition, new peaks were also
recorded in all the spectra of co-formers confirming the structural differences between API and co-
formers. In addition, percent growth inhibition was also observed by all the co-crystals through MTT
assay against HCT 116 colorectal cell lines in vitro. At four different concentrations; 25, 50, 100 and
200 mg/mL, slightly different trends of the effectiveness of API and co-crystals were observed.
However; among all the co-crystal forms, 5-FU-thiourea co-crystals obtained through solution method
(2B) proved to be the most effective growth inhibitor at all the four above mentioned concentrations.
 2019 The Author(s). Published by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cancer is abnormal and uncontrolled growth and multiplication
of cells. It is the second major cause of casualties each year. A num-
ber of treatment strategies and medicines have been explored and
evaluated. However, none of them is producing satisfactory out-
comes. Almost all the chemotherapy medicines have associated
drawbacks, and studies are being carried out to minimize their side
effects (Zhang, 2018). Chemical derivatization of an active pharma-
ceutical drug to mask its undesirable effects and to deliver unal-
tered at the site of action is a modern and fascinating approachto optimize the desired effects. The exploration of essential func-
tionalities of heterocyclic compounds in medicinal field is a widely
studied domain (Zha, 2019). Certain structural features of com-
pounds are responsible for their diverse activities (Zhao, 2018).
Nitrogen containing heterocyclic compositions are vital compo-
nents of many natural compounds e.g., antibiotics, vitamins and
nucleic acids (Jubeen, 2018; Rakesh, 2017; Moku, 2019; Wang,
2018). 5-fluorouracil (5-FU), antimetabolite of pyrimidine, a main-
stream anticancer drug has been studied widely since its discovery
in 1957 (Jubeen, 2018; Carrillo, 2015). The derivative of enone
functional group in 5-FU molecule is similar to many natural and
synthetic a,b-unsaturated carbonyl based compounds like chal-
cones, curcumin etc. responsible for antitumor activities having
strong antiproliferative potential (Qin, 2016, 2017; Zha, 2017).
5-FU administration, either intravenous, oral or topical has
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toxicity and other health related issues e.g., alopecia, vomiting,
diarrhoea (Radwan and Alanazi, 2014; Miura, 2010). For the reduc-
tion of side effects and short comes associated with 5-FU
chemotherapy, 5-FU and its derivatives are under keen
consideration.
Many derivatives of 5-FU have been formulated and studied fol-
lowing a number of different approaches. Derivatization with
macromolecules e.g., carbohydrates or lipid moieties were fabri-
cated for crossing the membrane barriers and improving the solu-
bility related drawbacks (Zhang, 2018; Petaccia, 2016; Köksal
Karayildirim, 2018). Considering the fact of pH difference in differ-
ent organs and tissues, a variety of pH sensitive prodrugs of 5-FU
has been designed for its targeted action (Ofonime Udofot, 2015).
Further working on target selectivity, 5-FU modification has also
been done with various DNA binders, a phenomenon termed as
DNA intercalation e.g., binding of DNA binder drugs to the N1 or
N3 or at both positions simultaneously (Zhou, 2013). Further head-
ing towards improving drug potency of 5-FU chemotherapy with
no or minimum side effects, a variety of 5-FU loaded nanoparticles
have been designed for improving surface to volume ratio resulting
in maximum drug entrapment and easy travelling to targeted tis-
sues (Tummala et al., 2015; Subudhi, 2015; Dong, 2019). Further-
more, co-crystallisation of 5-FU (active pharmaceutical
ingredient) with co-formers is an emerging and novel phenomenon
for reversible inactivation of 5-FU (Stoler and Warner, 2015).
Co-crystallisation of 5-FU is feasible and advantageous as it has
both hydrogen bond donor and acceptor groups (Nadzri, 2016). The
central focus lying behind increasing interest in this domain is easy
fabrication requirements i.e., designing methodologies of co-
crystals are comparatively easy, no requirement of costly and scar-
cely available instruments, feasible at room temperature, solvents
are required in a very low amount or sometimes solvent free
methodologies can also be followed (Douroumis et al., 2017;
Karimi-Jafari, 2018; Likhitha, 2019). Likewise, this phenomenon
is also free from side products formation or isolation and purifica-
tion. As this is a very new and innovative phenomenon, there is not
much work found in the literature.
Successful co-crystals of 5-FU were reported with some aro-
matic compounds, benzoic acid derivatives and heterocyclic com-
pounds (Delori et al., 2013; Mohana et al., 2017; Dai, 2016).
However, in none of the published studies, the safety of co-
formers regarding antimetabolites formation in the body is men-
tioned. Further, there is no evidence of any co-crystal reported in
the literature for their anticancer activity (MTT assay). Most of
the studies are mainly focused on the structure elucidation from
the point of view of the development of supra-molecular interac-
tions. Reported literature is lacking of the data regarding biological
activity of the synthesised co-crystals (Nadzri, 2016; Dai, 2016).
This research explains the fabrication of co-crystals of 5-FU
with four different compounds i.e., urea, thiourea, acetanilide and
aspirin. All the selected co-formers have hydrogen bond donor or
acceptor groups or both. In addition to the feasibility of supra-
molecular interactions, all of these four molecules manifest much
significance regarding their biological activities from a pharmaceu-
tical point of view. Further, their metabolism in the body does not
result in toxic metabolites so, this selection of co-formers is not
only safe for in-vivo administration but can also be helpful in the
improvement of 5-FU pharmacological properties (Langley and
Rothwell, 2012; Li, 2017; Rakesh, 2017). The major elements in
all the selected co-formers like F, S, O, N and H are among the
top ten elements in approved drugs (Fang, 2019). Co-crystals of
5-FU are prepared by following the solid-state grinding method
and solution method, with the use of methanol as a solvent.
Methanol was selected considering the non-reactivity of alcohols,
as the OH group in alcohols as leaving group cannot be easilyreplaced. In none of the protocols hazardous chemicals were
required. Further the required apparatus was economical and
easily available. No by-products were formed. Co-crystals grew
on ambient temperature and pressure (Ahmed, 2016). In short,
both the fabrication methodologies followed in this study clearly
manifest and fulfil the conditions of green synthesis (Ansari,
2019). Formation of supra-molecular interactions was evaluated
through FTIR and structural differences between API and co-
crystals were evaluated through powdered XRD analysis of fabri-
cated co-crystals. Comparative study of API and co-crystals from
the FTIR spectra proved the development of hydrogen bonding
interactions and the shift of characteristic 5-FU peak in PXRD
graphs of co-crystals proved the structural differences of 5-FU
and co-formers. Furthermore, in vitro anticancer assays of the
designed crystals are also performed for their biological evaluation.
All the co-crystals proved to be effective for the growth inhibition
of actinomycetesmore or less than the main API. Four different con-
centrations of actinomycetes were applied to variate the number of
viable cells and consequently the outcomes of synthesised co-
crystals at different concentrations were evaluated (Suthindhiran
and Kannabiran, 2009). The novelty of this study over others is
its analysis and identification approach for the selection of the
more prolific method for co-crystals fabrication from two available,
under standard conditions. Apart from this, the two of the synthe-
sised co-crystals are novel, has not been synthesised previously
including acetanilide and aspirin’s co-crystals with 5-FU. In litera-
ture, the co-crystals formation was mostly confirmed through XRD
analyses, but this research provides strong chemical shreds of evi-
dence of co-crystals formation by the help FTIR analyses in addi-
tion to XRD analyses.2. Experimental
2.1. Chemicals
5-FU was provided by (Sigma-Aldrich, 99%), other chemicals
used in the study are urea (Applichem Biochemica Chemical syn-
thesis services, 98%), thiourea (Merck KGaA, 98%), acetanilide
(UNI CHEM chemical reagents, 99%) and aspirin (AnalaR chemicals
Ltd. Poole England). Methanol (Merck KGaA, 99.5% purity) was
used to facilitate crystallisation and dissolution. All the chemicals
were used without further purification. Co-crystals of 5-FU are
designed with urea, thiourea, acetanilide and aspirin following
solid-state grinding method (Nadzri, 2016; Sonawane, 2014) and
solution method with little modification in the synthesis protocol
of (Moisescu-Goia et al., 2017).
2.2. Synthesis of co-crystals
2.2.1. Solid state grinding method
The calculated amounts, 4.4 mM, of API (0.572 g) and co-former
(acetanilide, 0.56 g; aspirin, 0.792 g; urea, 0.24 g and thiourea, 0.32
g) were weighed and mixed vigorously for about 30 minutes with
the help of motor and pestle, then the ground mass was dissolved
in methanol to form a solution (Sonawane, 2014). A clear solution
was obtained without heating in the case of acetanilide co-formers
while in all the other three cases heating was done to get a clear
solution. After the clear solution formation vials were cooled at
room temperature, covered with aluminium foil and placed for
crystal growth. Colourless crystals were obtained in all the four
cases
2.2.2. Non- grinding solution method
The weighed amounts of API and co-formers as mentioned
above were taken in 1:1 ratio, dissolved in methanol in separate
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solution of both the members. Then the hot solutions of API and
each co former were transferred in a single vial and warmed at
about 90–100 C for about 3 minutes, then these solutions were
cooled at room temperature, covered with aluminium foil with 1
hole in it and placed in a dark cupboard for evaporation and crystal
growth (Moisescu-Goia et al., 2017; Yan, 2009).2.3. Characterisation
2.3.1. FTIR and PXRD
In order to study the changes in vibrational modes of functional
groups responsible for hydrogen bonding, FTIR analysis was per-
formed. Spectra of co-crystals were compared to the spectrum of
5-FU alone and shifting of ANAH groups and -C@O from normal
peaks were evaluated to study the development of non-covalent
interactions for co-crystals formation (Moisescu-Goia et al.,
2017). The Co-crystals were further evaluated through PXRD
(Dai, 2016; Moisescu-Goia et al., 2017; Li et al., 2014). PXRD phe-
nomenon is based on constructive interference between
monochromatic X-rays and crystalline samples. X-rays were gener-
ated by cathode ray tube, filtered to get monochromatic rays,
assembled to concentrate and then directed towards the sample.
MTT assay was performed to bio-evaluate the as prepared co-
crystals (Petaccia, 2016; Fang, 2015).Table 1
Comparison of absorption peaks of groups responsible for supramolecular
interactions.
Sample ID v (C@O) cm1 v (NAH) str cm1
5-FU 1647.77 3409.02
5-FU-U (1A) 1633.23 3556.93, 3438.20
5-FU-U (1B) 1614.94 3437.62
5-FU-Th (2A) 1610.38 3599.96, 3493.97, 3376.24
5-FU-Th (2B) 1621.81 3568.20, 3388.06
5-FU-Ac (3A) 1663.09 3538.09, 3472.57
5-FU-Ac (3B) 1649.62 3499.40, 3555.67
5-FU-As (4A) 1678.63 3565.19, 3492.82
5-FU-As (4B) 1659.30 3496.39, 3560.132.3.2. In vitro MTT antitumor bioassay
HCT 116 human colorectal cancer cell line ATCCCCL-247TM
[(catalogue no: 91091005-1VL) Sigma Aldrich] was used. Cells
were cultured as a monolayer in T-75 flasks Costar, followed by
subculturing twice a week at 37 C in 5% CO2 and 100% relative
humidity supplied incubator and managed at low passage number
5 to 20. HCT 116 was cultured in McCoy’s 5A medium Gibco Glas-
gow, supplemented with 10% fetal bovine serum FBS (Qin, 2015);
Gibco, Glasgow, UK and 1% antibiotics (streptomycin, penicillin).
Adherent cells at a logarithmic growth phase were washed with
2 mL of PBS (phosphate buffered saline). Afterwards detached by
addition of 0.5 mL of 1X trypsin and incubated for 2–5 min at 37
C in the incubator. 100 mL complete growth media was added
per well in 96-well flat-bottom microplates. Then cells were
counted for desired densities by staining with trypan blue and
counted with a hemacytometer. Each well was inoculated at den-
sities of 1,000–100,000 cells per well (Fang, 2015). Afterward cells
were treated with different concentrations of actinomycete
extracts such as 12 , 25, 50 and 100 mg/mL. Actinomycetes,
gram-positive bacteria, have been recognized as sources of several
secondary metabolites, antibiotics and bioactive compounds that
affect microbial growth. The experiment was performed in tripli-
cates to avoid any error. Background control wells containing the
same volume of complete culture medium was included in each
experiment along with a positive control containing Triton X-100
and negative controls as well. The plate was incubated at 37 C
for 24 h in CO2 supplied humidified incubator (Vichai and
Kirtikara, 2006).
After 24 hours, 10 lL of 3-(4, 5-dimethyl thiazol-2-yl)-2, 5-
diphenyl tetrazolium bromide (MTT) was directly added in the cul-
ture media of each well. The plate was incubated for 4 hours at 37
C in 5% CO2 incubator. After incubation plate was removed from
the incubator and gently culture media was removed without dis-
turbing cells monolayer. Subsequently, 100 lL of DMSO (dimethyl
sulfoxide) was added in each well and plate was shaken to solubi-
lize formazan (Patel, 2009). Absorbance was recorded spectropho-
tometrically at 570 nm. The inhibitory rate was calculated and plot
graphs against all actinomycetes extract to evaluate their anti-
cancer activities. Subsequently, IC50 was calculated for eachextract. The growth inhibition rate was calculated by the following
equation:
%Mortality ¼ O:D control wellð Þ  O:D treated wellð Þ
O:D control wellð Þ  1003. Results and discussion
The type and the extent to which the interactions were devel-
oped between API and co-formers and their biological effectiveness
were evaluated through comparison of results of as synthesised co-
crystal with API.
3.1. Comparative analysis of the development of supramolecular
interactions by FTIR spectroscopy
Spectra of all the synthesised eight co-crystals were studied in
comparison to the API. The absorption frequencies of the main
peaks of interest involved in hydrogen bonding interactions are
arranged in Table 1. The main peaks of interest are those arising
from the absorption of NAH (hydrogen bond donor) and C@O
(Hydrogen bond acceptor) groups in all the spectra. In the IR
spectrum of 5-FU, a blunt peak at 3409.02 cm1 could be attributed
to v (NAH) while a broad pointed band of high intensity at
1647.77 cm1 could be attributable to absorption of C@O groups
(Abdelghani, 2017).
3.1.1. 5-FU-U (1A and 1B)
A strong absorption peak at 3438.20 cm1 and a low absorption
peak at 3556.93 cm1 showing hypochromic shift as compared to
5-FU in the spectrum of co-crystals of 5-FU-U obtained through
grinding method were found. The peak at 3438.20 cm1 in the
co-crystal spectrum had shown a regular hypochromic shift in
comparison to API (Fig. 5). While the other peak with a huge differ-
ence in absorption frequency and peak shape and size in compar-
ison to 5-FU may be arisen due to the NAH groups of urea. In
the other spectrum of 5-FU-U co-crystals obtained through solu-
tion method, a less pointed peak of medium intensity arose at
3437.62 cm1 following the exact blue shift in absorption fre-
quency of NAH groups of co-crystals as described in the published
literature on the same phenomenon (Nadzri, 2016).
In the co-crystals of 5-FU-U, synthesised through grinding
method Fig. 5 (1A), strong absorption peaks at 1633.23 cm1 and
1562.88 cm1 were representative of C@O absorption indicating
a bathochromic shift. While in solution method, Fig. 5 (1B),
1614.94 cm1 and 1559.95 cm1, could be the result of C@O
absorptions. In short, for 5-FU-U co-crystals, strong red shifts for
both the spectra of co-crystals were observed for carbonyl group
absorptions as compared to API indicating the stretching of C@O
bond and development of single bond character due to extensive
involvement of O-atoms in wander walls interactions as shown
Fig. 2. Proposed interactions between 5-FU-Th co-crystals
Fig. 3. Proposed interactions between 5-FU-Ac co-crystals.
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co-crystal spectrum of solution method were indicative of
increased stretching of -C@O bond due to increased supramolecu-
lar interactions developing the single bond character and reducing
the absorption frequency in turn. This suggests the more suitability
of solution method than grinding method for co-crystal fabrication
in this case.
3.1.2. 5-FU-Th (2A and 2B)
In the case of 5-FU-Th co-crystal; from all the three peaks for
NAH absorptions in co-crystal spectrum of grinding method,
3599.96, 3493.97, 3376.24 cm1, and two proposed peaks,
3568.20, 3388.06 cm1 in the spectrum of solution method
(Table 1), 3493.97 and 3568.20 cm1 attributable to NAH groups
of 5-FU were indicating the strong blue shift as compared to API
according to the general trend possibly due to the replacement of
stronger interactions in the co-formers and API alone, with the
weaker interactions while forming co-crystals (Fig. 2) resulting in
the less stretching of NAH bond which consequently appeared as
higher frequency peaks in the spectra. The extra peaks might be
as a result of NAH absorptions of co-formers.
In the case of 5-FU-Th co-crystals; peak at 1610.38 cm1 in the
spectrum of co-crystals of grinding method Fig. 6(2A) could be due
to carbonyl group absorption of 5-FU, and red shift could be easily
justified as the development of single bond character due to Wan-
der Walls interactions, while the hypochromically shifted peak in
the spectrum of solution method at 1621.81cm1 is either due to
C@O groups or it could also be due to the absorptions of NAH scis-
soring vibrations as shown in Fig. 6 (2A). More absorption fre-
quency of the NAH groups of co-crystals obtained through
solution method Fig. 6 (2B) is in support of greater feasibility of
solution method for 5-FU-Th co-crystals fabrication than grinding
method.
3.1.3. 5-FU-Ac (3A and 3B)
In the spectrum of 5-FU-Ac co-crystals obtained through grind-
ing method, Fig. 7 (3A), blue shift was observed for the v (NAH)
absorptions in co-crystals i.e., peaks were found at 3538.09 and
3472.57 cm1 in comparison to the spectrum of API. This hypo-
chromic effect is indicative of the strengthening of NAH bond
due to replacement of already present interactions with the newFig. 1. Proposed interactions between 5-FU-U co-crystals. Fig. 4. Proposed interactions between 5-FU-As co-crystals.
Fig. 5. Comparative FTIR spectra of 5-FU-U co-crystals fabricated by grinding (A)
and solution (B) method.
Fig. 6. Comparative FTIR spectra of 5-FU-Th co-crystals fabricated by grinding (A)
and solution (B) method.
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lar hydrogen bonding interactions of 5-FU (b) were replaced by b*
interactions making the NAH bond more stronger and shifting the
absorption towards shorter wavelength i.e., at 3538.09 and
3472.57 cm1 (Moisescu-Goia et al., 2017). The reason behind this
may be the attachment of acetanilide C to electron donating
methyl group which consequently enhanced the NAH bond
strength as compared to the C of 5-FU which was attached to
two inductively electron withdrawing N atoms.
Two blunt peaks were observed in the spectrum of 5-FU-Ac co-
crystals obtained through solution method Fig. 7 (3B) which could
be attributed to NAH absorption i.e., at 3555.67 cm1 and 3499.40
cm1. Both peaks followed a hypochromic shift as compared to API.
That significant change in absorption frequency was indicative of
major changes in the NAH interactions as explained for the co-
crystals obtained through the grinding method and illustrated in
Fig. 3.
Carbonyl groups in the co-crystal spectrum were found to exhi-
bit the most intense or second most intense peaks in the spectra.
There was significant hypochromic shift in the frequency of car-bonyl groups of co-crystals obtained through grinding method
than that of 5-FU, indicating the alteration of hydrogen bonding
interactions of carbonyl groups in 5-FU as shown in Fig. 3, there
was low possibility of b* as compared to c* due to the steric hin-
drance of methyl group in b*. The absorption frequency of carbonyl
groups in the spectrum of the solution method was also slightly
shifted in 5-FU and co-crystals. More absorption frequency of
NAH groups was indicative of more strengthening of this bond fol-
lowing solution method as compared to grinding method for co-
crystal fabrication. Lower absorption frequency of carbonyl groups
in the solution method was indicative that the development of sin-
gle bond character was more as a result of its involvement in
supramolecular interactions. After the discussion, the observations
are leading towards the development of 5-FU-Acetanilide co-
crystals, solution methodology is claimed to be more effective.3.1.4. 5-FU-As (4A and 4B)
Hypochromic shift in absorption frequencies of NAH in both the
spectra of 5-FU-As co-crystals was indicative of strengthening of
this bond possibly owing to replacement of already present inter-
actions with weaker interactions i.e., replacement of 5-FU with
aspirin molecules in the neighbor resulting in more strained and
less strong interactions which could be attributed to the bigger
molecular size of aspirin as compared to 5-FU as indicated in
Fig. 4, interactions b could be replaced by b* and d could be
replaced by d*.
In the spectrum, 5-FU-As, of co-crystals through grinding
method, absorption due to carbonyl groups of 5-FU are not visible
in the spectrum of co-crystals possibly in consequence of the
involvement of these carbonyl groups in supramolecular interac-
tions and lowering of double bond character due to increased
stretching and single bond character of carbonyl groups of 5-FU.
This evidence is further supported by a strong band in 1050-
1250 cm1 region responsible for C-O absorption (1242.00 cm1
and 1179.10 cm1). While the absorption frequency of carbonyl
group in the co-crystal spectrum of solution method Fig. 8 (4B)
was indicative of strong blue shift as compared to that of 5-FU. It
indicates the strengthening of the double bond character of C@O
group possibly due to the weakening of hydrogen bonding interac-
tions of O atom as shown in Fig. 4 through the interactions d which
could be replaced by d* and c could be replaced by c*. NAH absorp-
tion peaks were almost at same positions and were of same fre-
quency, so there was no significant change in those interactions
in the co-crystals obtained through both the methods. The car-
bonyl absorption frequency was lower for the co-crystals of solu-
tion method as compared to that of grinding method Fig. 8 (4A),
indicating the development of single bond character resulting
due to the involvement of oxygen of carbonyl group in hydrogen
bonding interactions. In short, for the co-crystal synthesis of 5-
FU-Aspirin, solution method might be more favourable than the
grinding method.
The hypochromic shift in absorption frequencies of NAH groups
(Dai, 2016) in the FTIR spectras of Figs. 5–8 are indicative of
strengthening of this bond possibly owing to a replacement of
already present interactions with weaker interactions resulting in
more strained and less strong interactions which could be attribu-
ted to the interference of different molecules (co-formers). These
prominent blue shifts in v (NAH) str cm1 absorption frequencies
in comparison to 5-FU were in exact accordance with the shifts
reported by Nadzri and co-workers (Nadzri, 2016). Considering
the 5-FU-acetanilide and 5-FU-aspirin, lower absorption frequency
of carbonyl groups in the solution method was indicative that the
development of single bond character was more as a result of its
involvement in supramolecular interactions. In the same way, the
absorption frequencies of NAH and C@O groups indicated that
Fig. 7. Comparative FTIR spectra of 5-FU-Ac co-crystals fabricated by grinding (A)
and solution (B) method.
Fig. 8. Comparative FTIR spectra of 5-FU-As co-crystals fabricated by grinding (A)
and solution (B) method.
F. Jubeen et al. / Saudi Pharmaceutical Journal 27 (2019) 1164–1173 1169for the synthesis of 5-FU-Urea and 5-FU-Th, solution method might
be more favourable than the grinding method.
3.2. Structural differentiation of API and co-crystals by PXRD
After a clear indication of more favorability of the solution
method, the co-crystals formation was further confirmed through
powdered XRD. The shifts in the peaks of 5-FU are significant in
all the co-crystal forms with respect to both the shapes of the
peaks and the intensity of the peaks. These shifts are clearly indica-
tive of the change in the structural characteristics of 5-FU due to
the change in intermolecular interactions with different co-
formers (Moisescu-Goia et al., 2017). From the stacked graph of
API and co-crystals Fig. 13, the most intense characteristic peak
of 5-FU recorded at 2h = 28.80 which is exactly equal to the value
reported in the study of Goia et al. (Moisescu-Goia et al., 2017).
This characteristic value of 5-FU seemed to be significantly shifted
in the graphs of all the co-crystals. For 5-FU-U (1B) co-crystals
(Fig. 13), the most intense peak is recorded at 2h = 28.19. The
intensity of this peak is much lower than that recorded for API‘s
characteristic peak manifesting the decreased preferred orienta-
tion. It means that the arrangement of molecules in a specific ori-
entation is not appreciable. The crystal size is also not significantly
bigger than the API and can be attributed to the smaller size of the
urea molecule. The obtained results proved the less crystallinity of
the synthesised co-crystals.
For 5-FU-Th (Fig. 13 2B) the most intense peak is recorded at
2h=27.97. The maximum value of intensity is recorded as com-
pared to API and all the co-crystal forms manifesting the enhanced
crystal packing in a specific orientation. The crystal size is also
quite bigger as compared to all the other cases except 5-FU aceta-
nilide possibly due to the smaller molecule of thiourea that aceta-
nilide. Now if we talk about 5-FU- Ac co-crystals (Fig. 13 3B), the
most intense peak found at 2h = 29.10. This peak is different from
that found in the graph of API not only in the position but also in its
intensity and FWHM values are varied significantly, than the val-
ues recorded for 5-FU (Table 3). The increase in the intensity value
is indicative of the increase in the preferred orientation because of
enhanced crystallinity. The much smaller value of the FWHM value
is indicative of the significant greater size of co-crystals than API
(Table 3) proving the presence of both the constituents in the syn-
thesised co-crystals. The obtained results prove the good crys-
tallinity and structural differences of co-crystals of 5-FU-Ac as
compared to API obtained through solution method.
The most intense peak of 5-FU-As (Fig. 13 4B) is recorded at 2h =
28.74. Although the difference in 2h value is smaller between API
and co-crystals, however, the intensity of this peak is much higher
than that of API proving the increased crystallinity of co-crystals.
The crystal size is quite smaller in this case. From the above men-
tioned facts, the least difference in 2h values is observed between
5-FU and aspirin. However, the difference in the peak shapes,
intensity and FWHM values are very much different in both the
API and 5-FU-As co-crystals.
For further clarity, the difference in intensities, 2h values and
FWHM values of most prominent peaks are arranged in the tabular
form (Table 3). In addition to the shift of 5-FU characteristic peaks,
there are many new peaks observed in the graphs of co-crystals
and many of the other peaks found in the graph of 5-FU are missing
in the graphs of co-crystals. The significant differences in the val-
ues and appearance of new peaks are indicative of the variations
in the already present 5-FU system manifesting the alterations in
already present supramolecular interactions due to the incorpora-
tion of different co-formers forming co-crystals. Crystallite size of
all the co-crystal and API is calculated from Scherrer equation
(Table 3) (Li et al., 2014). Although the size difference between
urea and thiourea is not significant, however the crystallite sizeof 5-FU-Th is almost double than that calculated for 5-FU-U
co-crystals. This significant difference might be attributed to the
most compact and strong hydrogen bonding interactions in 5-FU
urea co-crystals than that in the 5-FU-Th co-crystals.
This effect arises due to the involvement of all the groups of
urea in hydrogen bonding interactions while in thiourea, sulphur
in place of oxygen is not a good candidate for the development
of hydrogen bonding interactions leading to loose crystal packing.
This is also confirmed by FTIR results and fromMTT assay the more
anticancer potential of 5-FU thiourea co-crystals as compared to 5-
FU-U co-crystals also confirms the loose packing and easy release
of API. In short, the crystal size of all the co-crystals is also indica-
tive of the successful formation of strong hydrogen bonding inter-
actions as all the co-crystals are significantly bigger in size than the
5-FU alone manifesting the incorporation of co-formers with API,
forming supramolecular synthons.
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Figs. 9–12 explain the comparative study of the rate of % growth
inhibition in relation to changing the concentration of Actino-
mycetes, of the fabricated co-crystals via grinding (A) and solution
method (B). All the co-crystals proved to be effective for growth
inhibition to a variable extent against HCT 116 colorectal cell lines
in vitro. 5-FU manifested a gradual increase in percent growth inhi-
bition with the increase in the concentration of actinomycetes
Table 2 (Fang, 2015). Its maximum growth inhibition potential is
64.48% at 200 mg/mL concentration. This trend of increasing
growth inhibition with increasing concentration of actinomycetes
is very much rational i.e., as the concentration of microorganism’s
extract is increased, the drugs will have more targets to act upon
and consequently, the numerical values of inhibition will also
increase.
It is obvious that in all the cases percentage growth inhibition is
directly related to the actinomycetes concentration except forFig. 9. Comparison of percentage growth inhibition of 5-FU-U co-crystals, fabri-
cated by grinding (A) and solution (B) method, at varying concentrations of
actinimycetes against HCT 116 colorectal cell lines.
Fig. 10. Comparison of percentage growth inhibition of 5-FU-Th co-crystals,
fabricated by grinding (A) and solution (B) method, at varying concentrations of
actinimycetes against HCT 116 colorectal cell lines.5-FU-urea co-crystals obtained through grinding method (1A).
For 1A co-crystals this trend is diverted from the observed trend
only at 200 mg/mL i.e., for 1A co-crystals 100 mg/mL proved to be
the concentration responsible for highest growth inhibition of
40.255% while in all the rest of the cases in addition to API alone
200 mg/mL is the concentration responsible for maximum growth
inhibition as shown in Fig. 9. On the other hand, 1B co-crystals of
5-FU-U has a maximum anticancer potential of 45.7195% at 200
mg/mL. The observed difference in the anticancer potential of API
alone and co-crystals of 5-FU-U is attributed to the free and
bounded conditions of 5-FU (Fig. 9).
From Table 2 it is clearly observed that the co-crystals of 5-
FU-Th obtained through solution method (Fig. 10 (2B)) are much
more effective in the percent growth inhibition than that
obtained through grinding method Fig. 10 (2A). At all the four
concentrations the anticancer potential of 2B co-crystals are com-
parable to that of 5-FU. At 25 and 200 mg/mL, the effectiveness of
2B co-crystals is significantly greater than that of API alone asFig. 11. Comparison of percentage growth inhibition of 5-FU-Ac co-crystals,
fabricated by grinding (A) and solution (B) method, at varying concentrations of
actinimycetes against HCT 116 colorectal cell lines.
Fig. 12. Comparison of percentage growth inhibition of 5-FU-As co-crystals,
fabricated by grinding (A) and solution (B) method, at varying concentrations of
actinimycetes against HCT 116 colorectal cell lines.
Fig. 13. Comparison of PXRD spectra of API and Co-formers fabricated by solution
method (B).
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co-crystals is attributed to an antioxidant potential of thiourea
(Shakeel, 2016). It is clearly exhibited from Table 3, that the
anticancer potential of 5-FU-Ac cocrystals followed the same
trend as found for 5-FU-Th co-crystals i.e., Fig. 11 (3B) co-
crystals are more effective anticancer agents than Fig. 11 (3A)
except at 100 mg/mL. Now if the API and 3B co-crystals are com-
pared, both have comparable anticancer potential at all the four
concentrations possibly due to the larger molecule of acetanilideTable 3
Crystallite Size of 5-FU and Co-crystals using Scherrer equation (Reinsch, 2016).
Sample ID 2h Intensity H h
5-FU 28.80 1156 14.40 0
5-FU-U (1B) 28.19 938 14.09 0
5-FU-Th (2B) 27.97 5725 13.98 0
5-FU-Ac (3B) 29.10 1249 14.55 0
5-FU-As (4B) 28.74 2066 14.36 0
Table 2
Percentage inhibition of cancer cells HCT-116 using different concentrations.
Sample ID %age Inhibition of cancer cells HCT-116 using di
25 mg/mL 50 mg/mL
5FU 16.21 ± 0.20 39.53 ± 0.
1A 15.66 ± 0.64 24.04 ± 0.
1B 14.57 ± 0.57 30.97 ± 0.
2A 13.48 ± 0.59 18.21 ± 0.
2B 29.33 ± 0.89 36.43 ± 0.
3A 13.84 ± 0.57 22.04 ± 0.
3B 24.59 ± 0.60 35.15 ± 0.
4A 25.68 ± 0.54 33.35 ± 0.
4B 12.02 ± 0.56 22.12 ± 0.consequently weaker interactions with 5-FU leading to an easy
release of API.
Both the cocrystals of 5-FU-As follow the general trend of
increasing growth inhibition with increasing actinomycetes
concentration however; this is the only co-former in this study
whose Fig. 12 (4A), grinding method co-crystals exhibited greater
anticancer potential than 4B (Solution method). Aspirin‘s own
anticancer potential (Langley and Rothwell, 2012) made the 4A
co-crystals almost as effective as API at all the concentrations of
actinomycetes. The lesser effectiveness of 4B co-crystals can be
justified by the stronger hydrogen bonding interactions of 4B co-
crystals than 4A as evidenced from FTIR results leading to a slower
release of API (Fig.12). If we consider the comparative response of
all the co-crystals and API at individual concentrations, the follow-
ing trends were observed in the order of decreasing effectiveness.
At 25 mg/mL, and 200 mg/mL, 5-FU-Th (Fig. 10) co-crystals
obtained through solution method (2B) proved to be the co-
crystals responsible for maximum growth inhibition as shown in
Table 2 While at 50 mg/mL and 100 mg/mL API alone was the best
suited growth inhibitor. Increasing actinomycetes (target) concen-
trations increased the subsequent growth inhibition. However,
the rate of increase is different for all the co-formers due to the dif-
ferent nature of all the co-formers. The best outcomes of co-
crystals like 5-FU-Th regarding MTT assay might be attributed to
the readily release of the API and increased effectiveness as com-
pared to 5-FU are supposed to be due to the individual pharmaceu-
tical effectiveness of co-formers (Zhao, 2019).
As all the selected co-formers have their own proved pharma-
ceutical significance (Langley and Rothwell, 2012; Shakeel, 2016),
so these changes in the activity of 5-FU after the formation of co-
crystals very much rational and these trends might be attributed
to the individual properties of all the co-formers. From the
obtained results, it could be inferred that the solution method
might be the favourable one for the maximum growth inhibition
especially in the case of 5-FU-Th (2B) and 5-FU-Ac (3B) co-
crystals, confirms from Figs. 10 and 11. To the best of our knowl-
edge, MTT assays are not reported in any published study on 5-
FU co-crystals. Nadzri and co-workers (Nadzri, 2016) reported
anticancer activities of the synthesised co-crystals but the author
focused on the binding affinities of co-crystals with targeted pro-
tein, not on the percent growth inhibition. In another study, Dai
(2016), focused on the membrane permeability of synthesisedin Radians Cos h FWHM Crystallite Size (Å)
.25 0.97 0.24 6.01
.25 0.97 0.13 11.04
.24 0.97 0.06 22.48
.25 0.97 0.051 27.85
.25 0.97 0.16 9.09
fferent concentrations
100 mg/mL 200 mg/mL
56 54.28 ± 0.56 64.48 ± 1.21
59 40.26 ± 0.58 31.60 ± 0.53
58 41.71 ± 0.58 45.72 ± 0.57
63 37.16 ± 0.63 50.46 ± 0.60
60 51.91 ± 0.58 80.51 ± 0.59
57 40.07 ± 0.59 48.27 ± 0.58
62 35.3 ± 0.59 61.57 ± 0.60
60 50.27 ± 0.59 68.31 ± 0.58
60 34.61 ± 0.58 59.56 ± 0.88
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thesised co-crystals were performed and all the eight synthesised
co-crystals proved to be effective from the obtained results.
In addition to the evidences of co-crystal formation through
hydrogen bonding interactions and structural verification and its
biological effectiveness with the help of their in vitro cytotoxic
evaluation, it is important to add the significance and feasibility
of the methodologies opted for the synthesis. The marvellous phe-
nomenon of green chemistry was the aim behind the selection of
both the protocols to carry out the synthesis in the environment
friendly way with maximum output. The apparatus and chemicals
used were easily available and economical. All the chemicals used
were nonhazardous required in very low amount (Baumgartner,
2017). Further the selected co-formers were also not expensive.
All the co-crystals developed at ambient temperature and pressure
(Ahmed, 2016). The product gain in all the eight cases was maxi-
mum as there was no byproducts formation evidenced visually
or through FTIR and PXRD analysis. As there was no byproduct for-
mation, therefore, there was no stress to getting rid of waste
byproducts at the end of the synthesis. In short, the whole synthe-
sis process complies the rules of green chemistry devised by IUPAC
(Reinsch, 2016).
4. Conclusions
Eight different co-crystals were prepared. All four co-formers
were selected after a keen study on their pharmacological proper-
ties and subsequent metabolites. The successful co-crystals were
formed at room temperature following both the methodologies,
also supported by PXRD and FTIR results. Through both, the char-
acterization techniques, significant shifts in the anticipated peaks
of 5-FU were observed as the spectra of API and co-crystals were
studied in comparison. In all the FTIR spectra of co-crystals, the
main peaks of interest that are ANAH (3409.02 cm1) and AC@O
(1647.77 cm1) were significantly shifted than the spectrum of
5-FU following the same trend reported in the literature.
Through PXRD, the most intense characteristic peak of 5-FU is at
2h = 28.79918o. This peak is not only shifted in position in all the
graphs of co-crystals but also in intensity and FWHM values. More-
over, the appearance of new peaks in the graphs of co-crystals in
comparison to API proved the formation of new molecules.
5-FU-Ac co-crystals and 5-FU-Th co-crystals obtained through
solution method proved to be the co-crystals with the highest
trend of preferred orientation and increased crystallinity. MTT
assay proved that all the co-crystals manifested their activity
against HCT 116 colorectal cell lines. Through anticancer results,
again the 5-FU-Ac and 5-FU-Th co-crystals obtained through solu-
tion method proved to be the best agents for maximum growth
inhibition, agreeing with the result of FTIR and PXRD. In short, this
study is based on the very novel and the new phenomenon of co-
crystallisation. Due to its simplicity, cost-effectiveness, easy
fabrication protocols, no by-products formation and successful
derivatization of API, this phenomenon may prove to be effective
for future discoveries in cancer treatment. After the method
optimization and estimation of anticancer potential of these co-
crystals, the as prepared supramolecular synthons can be further
bio-evaluated for the estimation of their invivo safety. Moreover;
working in the same line many effective co-formers can also be
studied for their contribution in the anticancer domain that is actu-
ally the need of the hour.
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